págs. 291-292
Detecting pharmacovigilance signals: Data mining of benzodiazepines adverse reactions notified to FDA reporting system
Beatriz Proy Vega, Anselmo Martínez Blázquez, Julián Solís García del Pozo, Joaquín Jordán Bueso
págs. 294-303
María González Martínez, Francisco Apolo Carvajal, Daniele Alioto, Nuria Martínez Casanova, Iciar Cañamares Orbis, Eugenia Martínez Sánchez, Alicia Escudero Brocal, Betsabé Cáliz Hernández, Mª Teresa Llanos Garcia, Isabel Mayorga Bajo, Silvia Fernández Peña, Elena Capilla Santamaría, Ainhoa Aranguren Oyarzábal, María José Calvo Alcántara
págs. 304-311
Analysis of drug dosing adjustments in patients with chronic kidney disease
Muhammad Amer, Ur Rashid Nazir Saeed, Saleha Sadeeqa, Muhammad Kazim Zargaham, Sehran Saba, M Adnan Bashir
págs. 312-317
Assessment of adverse drug reactions in geriatric patients in rural tertiary care teaching hospital
Prakash Lalkota Bhanu, M. Kumaraswamy, Guddhoor Manjula, Sateesh Sravan, Korrapol Joel, Tripathi Priyank
págs. 318-322
Enzalutamide in metastatic castration-resistant prostate cancer before chemotherapy
María Dolores Alvarado Fernández, Inmaculada Reyes Torres, S. Fénix Caballero
págs. 328-331
Multiple cranial neuropathy and myasthenic syndrome secondary to nilotinib
Julia Sánchez Gundín, Félix González Martínez, L. Martínez Valdivieso, Amparo Flor García, Araceli Molina Medina, Dolores Barreda Hernández
págs. 332-334
Pharmaceutical contribution in postoperative bacterial ventriculitis: A case report
Sara Ortiz Pérez, José Manuel Caro Teller, Marta González Sevilla, Carmen García Muñoz, José Miguel Ferrari Piquero
págs. 335-336
Anakinra for the treatment of undifferentiated systemic auto-inflammatory disease
María Encina García Mayo, Lara González Freire, Rosario Olivera Fernández, Ana Belén Veiga Villaverde, Carlos Crespo Diz
págs. 337-339
© 2001-2024 Fundación Dialnet · Todos los derechos reservados